Studying tumor cells circulating in the blood makes it possible to track changes in cancer cells and optimize treatment.
For decades, laboratories have routinely adjusted test-result values of alpha fetoprotein by approximately 10% for Black mothers.
The device, which draws blood from capillaries in the skin, could someday replace standard blood draws for a variety of tests.
